Cargando...

A Preliminary Investigation of Naltrexone Augmentation of Bupropion to Stop Smoking With Less Weight Gain

Certain barriers prevent some cigarette smokers from attempting to quit, particularly the fear of post-cessation weight gain. This investigation was an open label study of naltrexone hydrochloride (25 mg/day) in combination with sustained-release (SR) bupropion hydrochloride (300 mg/day) for smoking...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Toll, Benjamin A., Leary, Vanessa, Wu, Ran, Salovey, Peter, Meandzija, Boris, O’Malley, Stephanie S.
Formato: Artigo
Idioma:Inglês
Publicado: 2007
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2488403/
https://ncbi.nlm.nih.gov/pubmed/17587504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.addbeh.2007.05.012
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!